Suppliers / Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical

Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical

China Updated 9 July 2026

Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical is an API manufacturer based in China. It holds 4 active US drug master files and one valid CEP across a filed portfolio of 5 molecules.

4
active US DMFs
1
valid CEPs
1
registered plants
1
filings across 1 regulators

Registered plants

Site FDA FEI
Suzhou City, China Not on file

What they file, and where

Molecule Regulators Docs
Degarelix US FDA 1
Linaclotide US FDA 1
Liraglutide US FDA 1
Octreotide EDQM 1
Semaglutide US FDA 1

Also appears on these molecule pages

Degarelix API Linaclotide API Liraglutide API Octreotide API Semaglutide API

Filings and GMP by regulator

Regulator Filings GMP certificates
EDA (EG) 1 None

Questions about Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical

Does Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical hold a US DMF or a CEP?
Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical holds 4 active US drug master files and 1 valid CEP. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical manufacture?
1 registered site is on record, in China (Suzhou City). Every site is listed on this page with the register it came from.
What does Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical make?
5 molecules are on record against Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical, including Degarelix, Linaclotide, Liraglutide and Octreotide. Each links through to that molecule's full manufacturer list.
Where does Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical file?
Filings are on record with EDA (EG), 1 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Hybio Pharmaceutical shares 4 molecules Auro Peptides shares 4 molecules Fresenius Kabi shares 3 molecules PolyPeptide shares 3 molecules Chengdu Shengnuo Biopharm shares 3 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability